Indoxyl sulfate induces retinal microvascular injury via COX-2/PGE2 activation in diabetic retinopathy

• Published in: Journal of translational medicine Vol. 22; no. 1; pp. 870 - 22
• Main Authors: Zhou, Lan, Sun, Hongyan, Chen, Gongyi, Li, Cunzi, Liu, Dan, Wang, Xurui, Meng, Ting, Jiang, Zhenyou, Yang, Shu, Yang, Ming-Ming
• Format: Journal Article
• Language: English
• Published: BioMed Central Ltd 27-09-2024; BMC
• Subjects: COX-2; Cyclooxygenases; Development and progression; Diabetic retinopathy; Health aspects; Indoxyl sulfate; Metabolites; Microcapillary damage; PGE2; Physiological aspects; Tryptophan metabolism; China
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-024-05654-1

Background Diabetic retinopathy (DR), the principal cause of acquired blindness among the working-age population, is the most frequent microvascular complication of diabetes. Although metabolic disorders are hypothesized to play a role in its pathogenesis, the underlying mechanism remains largely elusive. Methods To elucidate the mechanism, we initially compared metabolite profiles of vitreous fluid between 23 patients with DR and 12 non-diabetic controls using liquid chromatography/tandem mass spectrometry, identifying the distinct metabolite indoxyl sulfate (IS). Subsequently, streptozotocin (STZ)-induced diabetic and IS-injected rat models were established to examine the effects of IS on retinal microvasculature. RNA sequencing was conducted to identify potential regulatory mechanisms in IS-treated human retinal endothelial cells (HREC). Finally, target gene knockdown in HREC and treatment of IS-injected rats with inhibitors (targeting IS production or downstream regulators) were employed to elucidate the detailed mechanisms and identify therapeutic targets for DR. Results Metabolomics identified 172 significantly altered metabolites in the vitreous humor of diabetics, including the dysregulated tryptophan metabolite indoxyl sulfate (IS). IS was observed to breach the blood-retinal barrier and accumulate in the intraocular fluid of diabetic rats. Both in vivo and in vitro experiments indicated that elevated levels of IS induced endothelial apoptosis and disrupted cell junctions. RNA sequencing pinpointed prostaglandin E2 (PGE.sub.2) synthetase-cyclooxygenase 2 (COX-2) as a potential target of IS. Validation experiments demonstrated that IS enhanced COX-2 expression, which subsequently increased PGE.sub.2 secretion by promoting transcription factor EGR1 binding to COX-2 DNA following entry into cells via organic anion transporting polypeptides (OATP2B1). Furthermore, inhibition of COX-2 in vivo or silencing EGR1/OATP2B1 in HREC mitigated IS-induced microcapillary damage and the activation of COX-2/PGE.sub.2. Conclusion Our study demonstrated that indoxyl sulfate (IS), a uremic toxin originating from the gut microbiota product indole, increased significantly and contributed to retinal microvascular damage in diabetic retinopathy (DR). Mechanistically, IS impaired retinal microvascular integrity by inducing the expression of COX-2 and the production of PGE.sub.2. Consequently, targeting the gut microbiota or the PGE.sub.2 pathway may offer effective therapeutic strategies for the treatment of DR. Graphical Keywords: Indoxyl sulfate, Diabetic retinopathy, Microcapillary damage, COX-2, PGE.sub.2